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Posttranslational modiﬁcations play a crucial role in modulating protein structure and function.
Genetic incorporation of unnatural amino acids into a speciﬁc site of a protein facilitates the sys-
tematic study of protein modiﬁcations including acetylation. We here report the directed evolution
of pyrrolysyl-tRNA synthetase (PylRS) fromMethanosarcina mazei to create N-acetyl lysyl-tRNA syn-
thetases (AcKRSs) using a new selection system based on the killing activity of the toxic ccdB gene
product. The amino acid speciﬁcity of these and of published [1,2] AckRSs was tested in vitro and
in vivo, and the enzyme-kinetic properties of the AckRSs were evaluated for the ﬁrst time.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Posttranslational modiﬁcations (PTM) markedly expand the
natural repertoire of proteins by enlarging the diversity of func-
tional groups beyond those of naturally occurring 20 amino acids.
A wide range of cellular processes are governed by various types of
PTM, including phosphorylation, glycosylation, and acetylation [3].
Thus, elucidation of the molecular mechanisms and cellular func-
tions of PTM is fundamental to understanding the complicated bio-
logical system. For a systematic study of PTM, preparation of a
homogenously modiﬁed protein is essential. Many methods
including selective chemical modiﬁcations and native chemical
ligation have been developed, but these methods suffer from a lack
of generality [4]. They require tedious chemical synthesis and liga-
tion, and they can only be applied to N- and C-terminal modiﬁca-
tions. Hence, production of recombinant proteins with deﬁned and
homogenous modiﬁcation still remains a challenge.
Cotranslational insertion of an unnatural amino acid into a spe-
ciﬁc site of a protein is a powerful tool for investigating protein
structure and function relationship, probing protein function in bio-
logical processes, andmanipulating proteinswith tailor-made func-chemical Societies. Published by E
lar Biophysics and Biochem-
ey Avenue, New Haven, CT
partment of Chemistry, Korea
35 Gwahak-ro, Yuseong-gu,
2810 (H.-S. Park).
ark@kaist.ac.kr (H.-S. Park).tionalities. To date we know of a large number of unnatural amino
acids that have been genetically incorporated into proteins by pairs
of an engineered aminoacyl-tRNA synthetase (aaRS) and its cognate
suppressor tRNA; these pairs are orthogonal to the host tRNAs and
aaRSs [5–7]. N-Acetyl lysine has been site-speciﬁcally incorporated
into proteins through enzymes derived by evolution of PylRS [1,2].
Recently the molecular evolution of elongation factor (EF-Tu) [8]
has beenused for the successful incorporation of phosphoserine into
proteins. The genetic incorporation approach has proved effective at
producing homogenously modiﬁed proteins, but it often produces
relatively low levels of recombinant proteins (1–2 mg/l) in part
due to low in vivo charging activity of the evolved aaRSs.
Directed evolution experiments rely on two factors, generation
of diverse population and the use of the proper selection system. In
particular, the development of an efﬁcient selection method is of-
ten considered the most crucial step in these experiments, as illus-
trated in the phrase ‘‘you get what you select for’’ [9]. Most aaRS
evolution experiments have been based on CAT and barnase based
selection [1,5,10]. Since selection method signiﬁcantly affects the
outcome of directed evolution of enzymes, we reasoned that differ-
ent selection methods might generate different pools of positive
variants in the aaRS evolution experiments. Therefore, the develop-
ment of a distinct selection systemmight expedite the evolution of
aaRS with desirable in vivo charging activity, which might lead to
high yield production of recombinant proteins with deﬁned modi-
ﬁcations. In this report, we have constructed a new negative selec-
tion system based on the killing activity of the lethal ccdB gene and
applied this system to the evolution of AcKRS fromMethanosarcinalsevier B.V. All rights reserved.
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alytic properties of the evolved AckRSs were examined using both
in vivo charging and suppression experiments and in vitro ATP-PPi
exchange assay.
2. Materials and methods
2.1. General
N-Acetyl lysine (AcK) was purchased from Sigma. Oligonucleo-
tide synthesis and DNA sequencing were performed by the Keck
Foundation Biotechnology Resource Laboratory at Yale University.
All restriction enzymes and DNA polymerase were purchased from
New England Biolabs.
2.2. Plasmids construction
To generate a new negative selection system, we initially con-
structed pCB plasmid carrying pylT and ccdB gene with amber stop
codon on different sites using pTECH plasmid [11] and pZErO-2
vector (Invitrogen). We then generated pAraCB2 plasmid for tight
regulation of the ccdB gene by employing ara promoter and rrnB
terminator. More details are listed in Supplementary data.
2.3. MmPylRS mutant library construction and selection for AcK-
speciﬁc MmPylRS variants
For mutant library construction, six residues (L301, L305, Y306,
L309, C348, and W417) of M. mazei PylRS were randomly mutage-
nized by using eight primers and overlap extension PCR method
as described before [12]. TheMmPylRSmutant librarywas screened
through a serious of CAT and CcdB based selectionmethods. For the
ﬁrst positive selection, 50 ng of pKTS-MmPylS library plasmid was
introduced into 120 ll electrocompetent Escherichia coli TOP10
(4.2  109 cells) with positive selection plasmid pCAT-pylT that
has a mutant cat gene with an amber stop codon at position 112
and tRNAPyl. The transformants were recovered in 3 ml SOC at
37 C for 2 h. It was transferred and cultivated in 100 ml LB-TK
(containing 10 lg/ml Tet and 25 lg/ml Km) for 16 h at 37 C.
400 ll of the overnight culture was inoculated into 20 ml fresh
LB-TKack (LB-TK containing 1 mM AcK). After growing at 37 C for
4 h, 500 ll was plated on ten LB-TKCack (LB-TK containing 50 lg/
ml Cm and 1 mM AcK) plates. The plates were incubated at 37 C
for 42 h, all the colonies growing on the plates were scraped and
resuspended in 25 ml LB-TKack. After incubation for 5 h at 37 C,
plasmids were extracted and library plasmids were puriﬁed from
pCAT-pylT plasmids. For negative selection, 10 ng of pKTS-MmPylS
plasmids from the positive selection was transformed into 40 ll
electrocompetent E. coli TOP10 (1.2  109 cells) with negative
selection plasmid pAraCB2-pylT (see Supplementary data). The
transformants were recovered in 2 ml SOC at 37 C for 3 h, and then
60 ll was plated on six LB-CKara (containing 34 lg/ml Cm, 25 lg/
ml Km and 0.2% arabinose) plates. After incubation at 37 C for
24 h, the surviving colonies were scraped and pKTS-MmPylS plas-
mids were isolated and used for additional positive selection. Forty
eight colonies were selected at this stage and the suppression activ-
ity of individual colony was checked. Eleven clones were found to
show AcK-dependent growth on LB-TKCacK plate.3. Results and discussion
3.1. Design and construction of CcdB negative selection system
In E. coli, the ccd system (ccdA and ccdB) of the F plasmid is
responsible for the plasmid’s high stability by post-segregationalkilling of plasmid-free cells [13]. CcdB is a toxin targeting the
essential DNA gyrase while CcdA functions as an antitoxin. To con-
struct a negative selection system using the ccdB gene, we searched
for permissive site(s) allowing efﬁcient termination of an amber
stop codon and full restoration of the killing activity when the stop
codon is suppressed. We focused on the speciﬁc regions of the
CcdB protein (10–13 and 44–47 residues) because they are located
on the outside loop regions and not involved in dimerization or
interaction with the gyrase (Supplementary Fig. S1). We initially
constructed four kinds of pCB plasmids, pCB-R10-pylT, pCB-E11-
pylT, pCB-S12-pylT, and pCB-R13-pylT carrying pylT and the ccdB
gene (under the control of lac promoter) with stop codon at posi-
tion Arg10, Glu11, Ser12, or Arg13 (Supplementary Fig. S2A). tRNA-
Pyl and its anticodon mutants (opal and ochre suppressors) are
functional and orthogonal to E. coli aaRSs [14,15]. So, the efﬁciency
of translation termination of the mutant ccdB gene in the presence
of pylT is mainly dependent upon the nucleotide context of the stop
codon [16]. Analysis of the transformants of each plasmid revealed
that pCB-R13-pylT showed the lowest non-speciﬁc readthrough le-
vel but it still showed a retarded growth (Supplementary Fig. S2B).
We next introduced second amber stop codon at position 44 to
construct pCB-R13D44-pylT. A growth phenotype of the transfor-
mants with pCB-R13D44-pylT was indistinguishable from that of
the cells devoid of the ccdB gene (Supplementary Fig. S2B). When
pylT gene was replaced with a suppressor tRNAGln (supE), the trans-
formants of pCB-R13D44-supE could not grow. We then con-
structed pAraCB2-pylT plasmid carrying ccdB gene with double
stop codons under the control of ara promoter for a tight and rapid
regulation (Supplementary Fig. S2C). To further verify the efﬁ-
ciency of CcdB selection system, we examined whether the selec-
tion system worked for an orthogonal M. mazei PylRS and its
cognate tRNA pair (MmPylRS/tRNAPyl). The transformants with
pAraCB2-pylT/pKTS and those with pAraCB2-pylT/pKTS-MmPylRS
showed normal growth pattern with or without arabinose, sug-
gesting negligible level of background ccdB gene expression (Sup-
plementary Fig. S2D). On the other hand, the transformants with
pAraCB2-pylT/pKTS-MmPylRS could not survive in the presence
of N-cyclopentyloxycarbonyl-L-lysine (Cyc), a pyrrolysine analog
for MmPylRS [17]. These results clearly showed that the CcdB
selection system worked well for an orthogonal MmPylRS/tRNAPyl
pair and it can be applied for the evolution of aaRS/tRNA pair for
the incorporation of unnatural amino acids with diverse
functionalities.
3.2. Evolution of PylRS using CcdB selection system
To test the idea that a distinct selection system might generate
somewhat different pools of positive variants of aaRS, we set out to
evolve MmPylRS/tRNAPyl pair to incorporate AcK by using CAT and
CcdB based selection system. We ﬁrst designed and generated a li-
brary of MmPylRS variants, where six residues (L301, L305, Y306,
L309, C348, and W417) forming pyrrole ring binding pocket in
the active site were randomized based on MmPylRS and pyrroly-
sine complex structure [18,19]. A library of 1.5  108 MmPylRS
variants was introduced into E. coli TOP10 carrying tRNAPyl and
subjected to a series of positive and negative selections as de-
scribed in the Methods. After second positive selection, 11 clones
were isolated. Sequence analysis revealed that they were two dif-
ferent clones with four mutations; L301M, Y306L, L309A, C348F
for MmAcKRS1, and L301M, Y306L, C348S and an undesigned
mutation A315V for MmAcKRS2 (Table 1). Sequence comparison
revealed that the mutation proﬁle of the evolved MmAcKRSs dif-
fered from that of MbAcKRSs, although equivalent amino acid posi-
tions were randomized (Table 1). While barnase system produced
MbPylRS variants with the same mutations on three residues
L270I, L274A, C313F [1,2], MmAcKRS mutants selected by using
Table 1
Sequence comparison of MmAcKRSs and MbAcKRSs.
MmPylRS L301 L305 Y306 L309 C348 W417 Reference
MmAcKRS1 M L L A F W This work
MmAcKRS2a M L L L S W This work
MbAcKRS1 V I F A F W [1]
MbAcKRS2 L I L A F W [1]
MbAcKRS3 M I F A F W [2]
MbPylRS L266 L270 Y271 L274 C313 W383
Consensus sequences are shown in bold or italic type.
a This variant has an additional mutation A315V.
Table 2
Kinetic parameters of AckRSs determined by ATP-PPi exchange assays.
Enzyme Lysine N-Acetyl lysine
Km (mM) Kcat (s1) Km (mM) Kcat (s1)
MmAcKRS1 ND ND 35.3 ± 10.9 0.0323 ± 0.00606
MmAcKRS2 ND ND 7.80 ± 2.14 0.00731 ± 0.000767
MbAcKRS3 ND ND 22.3 ± 4.35 0.0341 ± 0.00297
ND, the kinetic constants could be not be calculated because the signal was
undetectably low.
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Fig. 2. In vivo b-galactosidase assay of the selected AcKRSs in the presence or
absence of AcK.
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L301M, L305, and Y306L. These results suggest that different selec-
tion systems may produce different pools of mutant clones possi-
bly due to the differences in action mechanism or degree of
stringency in the selection. However, other explanations are also
possible. Interestingly, W417 in MmPylRS or W383 in MbPylRS
was not changed in all AcKRSs, suggesting that W417 in MmPylRS
may be crucial for the recognition of wide range of lysine analogs
[19,20].
3.3. Characterization of evolved AcKRSs
In vivo aminoacylation activity of the evolved AcKRSs was ana-
lyzed by acid urea gel electrophoresis. The level of aminoacylation
was visualized by Northern hybridization (Fig. 1). While wild type
MmPylRS had a negligible charging activity for AcK, the evolved
synthetases (MmAcKRS1 and MmAcKRS2) were able to acylate
only AcK (not natural amino acids) onto tRNAPyl, generating AcK-
tRNAPyl. The aminoacylation products were deacylated when trea-
ted with alkali (200 mM Tris–HCl, pH 9.5). To conﬁrm these data,
the in vitro activity of a truncated AcKRS version was measured
in the ATP-PPi exchange reaction as described earlier ([21]; see
Supplementary data). Since there is a lack of studies reporting en-
zyme-kinetic properties of evolved orthogonal tRNA synthetases
we perceived it essential that in vitro characterization of the PylRS
variants from this study (MmAcKRS1 and MmAcKRS2) and from
the original report (MbAcKRS3) [2] should be performed. PylRS is
a fairly insoluble protein; thus the crystal structures and most of
the original biochemical data of this enzyme were performed with
a truncated PylRS version devoid of the variable N-terminal do-
main of the enzyme [18,19,22]. The truncated catalytic domain of
PylRS was reported to aminoacylate tRNAPyl with pyrrolysine with
slightly lower efﬁciency than the full length PylRS [19]. We at-tRNAPyl
tRNAPyl
MmPylRS                   AARS
Ack
AcK-tRNAPyl
Alkali
Fig. 1. In vivo aminoacylation of tRNAPyl with AcK by AcKRS1 and AcKRS2. Total tRNA
AcKRS1, or AcKRS2 after grown in the presence or absence of 5 mM AcK. The samples
hybridized with a tRNAPyl-speciﬁc oligonucleotide probe. The positions of tRNAPyl and Atempted to determine the kinetic constants for AcK, lysine, and
the pyrrolysine analog N-cyclopentyloxycarbonyl-L-lysine (Cyc) in
the ATP-PPi exchange reaction (Table 2). The initial experiments
revealed that Lys cannot be activated by any of the three enzymes,
while Cyc is slightly activated by MmAcKRS2 (but the activity is
too low to calculate any constants), but not by the two other en-
zymes. The evolved MmAcKRS1 and MmAckRS2 have good sub-
strate speciﬁcity in recognizing AcK. Both MmAckRSs do not
show any detectable activity toward lysine, which is in good agree-
ment with in vivo charging results (Fig 1). In addition, the con-
stants for a previously reported [2] enzyme, MbAcKRS3 (see
Table 1), were also determined. This enzyme has an in vitro activityMmAckRS1                 MmAckRS2 
was extracted from E. coli TOP10 co-transformed with pylT and the gene for PylRS,
were loaded onto an acid urea gel, transferred to a nitrocellulose membrane, and
cK-tRNAPyl are indicated.
CAT
MmAcKRS1/tRNAPyl
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Fig. 3. Expression and analysis of a AcK-incorporated reporter protein. (A) Puriﬁed CAT wild type and CAT-AcK mutant resolved on 10% SDS–PAGE. (B) ESI-MS analysis of the
puriﬁed CAT wild type (left) and CAT-AcK mutant (right).
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MmAcKRS1. Regarding kcat, the evolved AcKRSs (MmAckRS1 and
MbAckRS3) showed a comparable value to the wild-type PylRS
(around 2 min1 for AckRSs and 6 min1 for PylRS [23]). However,
their Km values were much higher, which may be due to imperfect
AcK binding. This is not unexpected, since the change in only ﬁve
amino acid residues of PylRS obviously is not generating an ideal
amino acid binding site for AcK in the newly evolved synthetases.
To further examine the properties of the selected MmAcKRSs,
we performed b-galactosidase assay where the suppression of lacZ
gene with an amber stop codon at position 3 (Met) was measured.
MmAcKRS1 and MmAcKRS2 both showed high levels of suppres-
sion activity only in the presence of AcK, proving that they were
evolved to become AcK-speciﬁc aminoacyl-tRNA synthetases
(Fig. 2). In particular, in vivo suppression activity of MmAcKRS1
was around ten and two times higher than that of previously re-
ported AcKRSs, MbAcKRS1 and MbAcKRS3, respectively [1,2]. This
in vivo assay produced different results than our in vitro ATP-PPi
experiments, where the MmAcKRS1 and MmAcKRS2 showed a lit-
tle lower catalytic efﬁciency than MbAcKRS3 (Table 2). One of the
reasons may be that the truncated AcKRSs were used in ATP-PPi
exchange analysis due to the limited solubility of PylRS [18,19].
The truncated AcKRSs may not fully represent in vivo performance
of intact enzymes, since the in vivo approach measures translation
as a whole while the in vitro approach measures only the behavior
of a pure enzyme and a pure substrate.
To demonstrate that AcK can be incorporated into proteins with
high ﬁdelity and yield by the evolved MmAckRSs, we transformed
E. coli TOP10 with pKTS-MmAcKRS1 and pCAT-pylT encoding cat
gene with an amber stop codon (112Asp) and C-terminal hexahis-
tidine tag. The transformants were cultured in LB medium supple-
mented with appropriate antibiotics and 20 mM nicotinamide and
induced for protein expression with 0.5 mM IPTG for 12 h at 30 C
in the presence or absence of 2 mM AcK. The cells produced full
length CAT recombinant proteins only when incubated with AcK
with a yield of 6 mg/l of culture (Fig. 3A), which is several times
higher than the yields by previously reported MbAcKRSs that lie
in the range of 1–2 mg/l [1,2]. This agrees well with in vivo sup-
pression data. To conﬁrm the incorporation of AcK, puriﬁed his-
tagged wild type CAT and mutant CAT-AcK were analyzed by elec-
trospray ionization mass spectrometry (ESI-MS). Mass spectrum of
CAT and CAT-AcK revealed that cysteine side chains are modiﬁed
by b-mercaptoethanol (b-ME), leading to a 76 Da mass increase.
In vitro chemical modiﬁcation b-ME during protein puriﬁcationhas been reported [24]. Wild type CAT generated two main peaks
(26918 and 26994 Da), representing the masses of CAT with single
and double b-ME adduct (expected mass 26918 and 26994 Da,
respectively) (Fig. 3B left). ESI-MS analysis of CAT-AcK showed
three major peaks (26898, 26974, and 27049 Da) corresponding
to CAT-AcK (expected mass 26897 Da) and two different species
with single or double b-ME (expected mass 26973 and 27049 Da
respectively) (Fig. 3B right). The mass of CAT-AcK is 55 Da bigger
than that of CAT because Asp112 is substituted by AcK. No deacet-
ylated byproduct of CAT-AcK was detected. (Mass spectra before
deconvolution are shown in Supplementary Figs. S3 and S4).
4. Concluding remarks
In this report, we demonstrated the evolution of AcKRS from
M. mazei PylRS using a new selection system based on the killer
gene ccdB. The selected MmAcKRS variants exhibited different
mutation proﬁle and showed higher in vivo suppression activities
than the previously reported MbAcKRS variants [1,2]. We also
determined the catalytic characteristics of the evolved AckRSs.
To our knowledge, this is the ﬁrst description of the kinetic prop-
erties of AcKRS enzymes. It is obvious, that the afﬁnity of AcK for
its evolved enzyme is very low, about 500–1000 times lower
than the standard afﬁnity of an amino acid for its cognate amino-
acyl-tRNA synthetase [25]. A rare biochemical study of an azido-
norleucine activating enzyme evolved from methionyl-tRNA
synthetase showed it to be 2750-fold less active than the parent
enzyme [26]. Thus, a similar drop in activity is likely in many of
the currently laboratory-evolved ‘orthogonal’ synthetase en-
zymes. This then poses new challenges to enzyme engineering
(with larger library sizes and possibly better selection schemes).
The lower rate of aminoacyl-tRNA formation may explain the
lower yields of recombinant proteins with non-natural amino
acids than is expected for recombinant proteins containing only
standard amino acids.
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